Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant homodimer of the human annexin V

EU orphan designation number: EU/3/11/946
Active ingredient: Recombinant homodimer of the human annexin V
Indication: Prevention of ischaemia/reperfusion injury associated with solid organ transplantation
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, NL-2333 BE Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2012 Centralised Orphan - Designation EMA/OD/103/11 (2012)132 of 11/01/2012
05/02/2013 Other procedure
11/02/2014 Centralised Orphan - Removal of orphan designation from Community Register